<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Recommended indications for MOG-IgG testing in patients presenting with acute CNS demyelination of putative autoimmune etiology</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Recommended indications for MOG-IgG testing in patients presenting with acute CNS demyelination of putative autoimmune etiology</h1>
<div class="graphic"><div class="figure"><div class="ttl">Recommended indications for MOG-IgG testing in patients presenting with acute CNS demyelination of putative autoimmune etiology</div><div class="cntnt"><table cellspacing="0"><colgroup width="100%"></colgroup> <tbody> <tr> <td> <ol> <li>Monophasic or relapsing acute optic neuritis, myelitis, brainstem encephalitis, encephalitis, or any combination thereof, and</li> </ol> </td> </tr> <tr> <td> <ol start="2"> <li>Radiologic or, only in patients with a history of optic neuritis, electrophysiologic (VEP) findings compatible with CNS demyelination, and</li> </ol> </td> </tr> <tr> <td> <ol start="3"> <li>At least one of the following findings:</li> </ol> </td> </tr> <tr> <td class="indent2"><strong>MRI</strong> <ol style="list-style-type: lower-alpha;"> <li>Longitudinally extensive spinal cord lesion (≥3 VS, contiguous, so-called LETM)</li> <li>Longitudinally extensive spinal cord atrophy (≥3 VS, contiguous) in patients with a history compatible with acute myelitis</li> <li>Conus medullaris lesions, especially if present at onset</li> <li>Longitudinally extensive optic nerve lesion (eg, &gt;1/2 of the length of the pre-chiasmal optic nerve, T2 or T1/Gd)</li> <li>Perioptic Gd enhancement during acute ON</li> <li>Normal supratentorial MRI in patients with acute ON, myelitis and/or brainstem encephalitis</li> <li>Brain MRI abnormal but no lesion adjacent to a lateral ventricle that is ovoid/round or associated with an inferior temporal lobe lesion and no Dawson finger-type or juxtacortical U fiber lesion</li> <li>Large, confluent T2 brain lesions suggestive of ADEM</li> </ol> </td> </tr> <tr> <td class="indent2"><strong>Funduscopy</strong> <ol start="9" style="list-style-type: lower-alpha;"> <li>Prominent papilledema/papillitis/optic disc swelling during acute ON</li> </ol> </td> </tr> <tr> <td class="indent2"><strong>CSF</strong> <ol start="10" style="list-style-type: lower-alpha;"> <li>Neutrophilic CSF pleocytosis or CSF white cell count &gt;50/microL</li> <li>No CSF-restricted OCB as detected by IEF at first or any follow-up examination (applies to continental European patients only)</li> </ol> </td> </tr> <tr> <td class="indent2"><strong>Histopathology</strong> <ol start="12" style="list-style-type: lower-alpha;"> <li>Primary demyelination with intralesional complement and IgG deposits</li> <li>Previous diagnosis of "pattern II MS"</li> </ol> </td> </tr> <tr> <td class="indent2"><strong>Clinical findings</strong> <ol start="14" style="list-style-type: lower-alpha;"> <li>Simultaneous bilateral acute ON</li> <li>Unusually high ON frequency or disease mainly characterized by recurrent ON</li> <li>Particularly severe visual deficit/blindness in one or both eyes during or after acute ON</li> <li>Particularly severe or frequent episodes of acute myelitis or brainstem encephalitis</li> <li>Permanent sphincter and/or erectile disorder after myelitis</li> <li>Patients diagnosed with "ADEM," "recurrent ADEM," "multiphasic ADEM," or "ADEM-ON"</li> <li>Acute respiratory insufficiency, disturbance of consciousness, behavioral changes, or epileptic seizures (radiological signs of demyelination required)</li> <li>Disease started within four days to approximately four weeks after vaccination</li> <li>Otherwise unexplained intractable nausea and vomiting or intractable hiccups (compatible with area postrema syndrome)</li> <li>Coexisting teratoma or NMDAR encephalitis (low evidence)</li> </ol> </td> </tr> <tr> <td class="indent2"><strong>Treatment response</strong> <ol start="24" style="list-style-type: lower-alpha;"> <li>Frequent flare-ups after intravenous methylprednisolone, or steroid-dependent symptoms (including CRION)</li> <li>Clear increase in relapse rate following treatment with interferon-beta or natalizumab in patients diagnosed with MS (low evidence)</li> </ol> </td> </tr> </tbody></table></div><div class="graphic_footnotes">MOG-IgG: myelin oligodendrocyte glycoprotein immunoglobulin G autoantibody; CNS: central nervous system; VEP: visual evoked potentials; MRI: magnetic resonance imaging; VS: vertebral segment; LETM: longitudinally extensive transverse myelitis; Gd: gadolinium; ON: optic neuritis; ADEM: acute disseminated encephalomyelitis; CSF: cerebrospinal fluid; OCB: oligoclonal bands; IEF: isoelectric focusing; IgG: immunoglobulin G; MS: multiple sclerosis; NMDAR: N-methyl-D-aspartate receptor; CRION: chronic relapsing inflammatory optic neuropathy.</div><div class="graphic_reference">Adapted from: Jarius S, Paul F, Aktas O, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 2018; 15:134. DOI: <a href="https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1144-2" target="_blank">10.1186/s12974-018-1144-2</a>. Copyright © 2018 Jarius S, Paul F, Aktas O, et al. Reproduced under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License 4.0</a>.</div><div id="graphicVersion">Graphic 117813 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
